{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:10:41Z","timestamp":1770279041881,"version":"3.49.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.arbres.2009.10.008","type":"journal-article","created":{"date-parts":[[2009,12,5]],"date-time":"2009-12-05T09:21:30Z","timestamp":1260004890000},"page":"244-254","source":"Crossref","is-referenced-by-count":18,"title":["Utilidad de los macr\u00f3lidos como antiinflamatorios en las enfermedades respiratorias"],"prefix":"10.1016","volume":"46","author":[{"given":"Daniel","family":"Sevilla-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolors","family":"Soy-Muner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9stor","family":"Soler-Porcar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2009.10.008_bib1","first-page":"1185","article-title":"Drug therapy reviews: Antimicrobial spectrum, pharmacology and therapeutic use of erythromycin and its derivatives","volume":"36","author":"Meade","year":"1979","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.arbres.2009.10.008_bib2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0891-5520(20)30694-2","article-title":"The newer macrolides: Azithromycin and clarithromycin","volume":"9","author":"Zuckerman","year":"1995","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.arbres.2009.10.008_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.ftd.0000195617.69721.a5","article-title":"Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis","volume":"28","author":"Wilms","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.arbres.2009.10.008_bib4","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1128\/AAC.49.12.5013-5017.2005","article-title":"Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis","volume":"49","author":"Beringer","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/joc.2001.13.1.3","article-title":"Immunomodulation by macrolide antibiotics","volume":"13","author":"Labro","year":"2001","journal-title":"J Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3565(24)35272-3","article-title":"Anti-inflammatory activity of macrolide antibiotics","volume":"292","author":"Ianaro","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.arbres.2009.10.008_bib7","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/AAC.39.8.1688","article-title":"Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections","volume":"39","author":"Tamaoki","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1378\/chest.122.1.213","article-title":"Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion","volume":"122","author":"Tagaya","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2009.10.008_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1164\/ajrccm\/141.1.72","article-title":"Erithromycin inhibits respiratory glycoconjugate secretion from human airways in vitro","volume":"141","author":"Goswami","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.arbres.2009.10.008_bib10","first-page":"439","article-title":"Effects of erythromycin on neutrophil chemotaxis to the lung tissue","volume":"159","author":"Ninomiya","year":"1991","journal-title":"J Clin Exp Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1164\/ajrccm\/146.1.196","article-title":"Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients","volume":"146","author":"Ichikawa","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.arbres.2009.10.008_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijantimicag.2004.03.022","article-title":"Macrolide antibiotics induce apoptosis of human peripheral lymphocytes in vitro","volume":"24","author":"Ishimatsu","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.arbres.2009.10.008_bib13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.intimp.2004.05.011","article-title":"Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL","volume":"4","author":"Mizuenoe","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.arbres.2009.10.008_bib14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1183\/09031936.06.00001506","article-title":"Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages","volume":"28","author":"Hodge","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2009.10.008_bib15","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1128\/AAC.47.3.1161-1164.2003","article-title":"In vitro effects of ciprofloxacin and roxithromycin on apoptosis of jurkat T lymphocytes","volume":"47","author":"Jun","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/AAC.47.1.48-53.2003","article-title":"Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages","volume":"47","author":"Yamaryo","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/rmed.1999.0781","article-title":"Erytrhomycin inhibits beta-2-integrins (CD11b\/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils","volume":"94","author":"Lin","year":"2000","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib18","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1183\/09031936.95.08091451","article-title":"Effect of erythromycin on Haemophillus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronquial epithelial cells","volume":"8","author":"Khair","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2009.10.008_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/147323000102900609","article-title":"Effects of roxithromycin on adhesion molecules expressed on endothelial cells of the dermal microvasculature","volume":"29","author":"Akamatsu","year":"2001","journal-title":"J Int Med Res"},{"key":"10.1016\/j.arbres.2009.10.008_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2249.1996.46752.x","article-title":"Inhibitory effect of clarithromycin on co-stimulatory molecule expression and cytokine production by synovial fibroblast-like cells","volume":"104","author":"Matsuoka","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.arbres.2009.10.008_bib21","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/AAC.40.6.1366","article-title":"Modulatory effect of antibiotics on cytokine production by human monocytes in vitro","volume":"40","author":"Morikawa","year":"1996","journal-title":"J Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09629359990351","article-title":"Suppressive activity of a macrolide antibiotic, roxithromycin, on pro-inflammatory cytokine production in vitro and in vivo","volume":"8","author":"Suzaki","year":"1999","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.arbres.2009.10.008_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0924-8579(98)00091-0","article-title":"Effect of clarithromycin and azithromycin on production of cytokines by human monocytes","volume":"11","author":"Khan","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.arbres.2009.10.008_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/46.2.235","article-title":"Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae","volume":"46","author":"Schultz","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib25","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/AAC.43.4.907","article-title":"Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors","volume":"43","author":"Kohyama","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib26","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/S1567-5769(01)00116-3","article-title":"Modulation of Th2 type cytokine production from human peripheral blood leukocytes by a macrolide antibiotic, roxithromycin, in vitro","volume":"1","author":"Asano","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.arbres.2009.10.008_bib27","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1128\/AAC.01142-06","article-title":"Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells","volume":"51","author":"Cigana","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-2999(02)02042-3","article-title":"Azitrhomycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects","volume":"450","author":"Culic","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.arbres.2009.10.008_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2006.03.074","article-title":"Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice","volume":"539","author":"Tkalcevic","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.arbres.2009.10.008_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0952-3278(03)00089-9","article-title":"Macrolide antibiotics inhibit prostaglandin E2 synthesis and mRNA expression of prostaglandin synthetic enzymes in humans leukocytes","volume":"69","author":"Miyazaki","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.arbres.2009.10.008_bib31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1165\/rcmb.2003-0105OC","article-title":"Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release","volume":"30","author":"Yamasawa","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.arbres.2009.10.008_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000196461","article-title":"Inhibition by erythromycin of superoxide anion production by human polymorphonuclear leukocytes through the action of cyclic AMP-dependent protein kinase","volume":"62","author":"Mitsuyana","year":"1995","journal-title":"Respiration"},{"key":"10.1016\/j.arbres.2009.10.008_bib33","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/AAC.49.7.2986-2989.2005","article-title":"The macrolide roxithromycin impairs NADPH oxidase activation and alters translocation of its cytosolic components to the neutrophil membrane in vitro","volume":"49","author":"Abdelghaffar","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/09629350310001599620","article-title":"Suprressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice","volume":"12","author":"Terao","year":"2003","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.arbres.2009.10.008_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000086922","article-title":"Effects of clarithromycin on inflammatory cell mediator release and survival","volume":"51","author":"Borszcz","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.arbres.2009.10.008_bib36","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/AAC.43.11.2678","article-title":"Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells","volume":"43","author":"Aoki","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/bbrc.1998.9697","article-title":"Glutathione down-regulates the phosphorylation of I kappa B: Auto-loop regulation of the NF-kappa B-mediated expression of NF-kB subunits by TNF-alpha in mouse vascular endotelial cells","volume":"253","author":"Cho","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arbres.2009.10.008_bib38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1203\/PDR.0b013e318142582d","article-title":"Azitrhomycin suppresses activation of nuclear factor kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants","volume":"62","author":"Aghai","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.arbres.2009.10.008_bib39","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.48.5.1581-1585.2004","article-title":"Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: Possible role in the signaling pathway that regulates nuclear factor-kappaB activation","volume":"48","author":"Desaki","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dkf008","article-title":"Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors","volume":"49","author":"Kikuchi","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib41","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/AAC.50.5.1738-1744.2006","article-title":"Clarithromycin delays progression of bronchial epithelial cells from G1 phase to S phase and delays cell growth via extracellular signal-regulated protein kinase suppression","volume":"50","author":"Shinkai","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1010975124110","article-title":"Signaling by the JNK group of MAP kinases, c-jun N-terminal Kinase","volume":"21","author":"Dong","year":"2001","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.arbres.2009.10.008_bib43","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/AAC.48.9.3457-3461.2004","article-title":"Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells","volume":"48","author":"Imamura","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib44","doi-asserted-by":"crossref","first-page":"L847","DOI":"10.1152\/ajplung.00216.2002","article-title":"Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis","volume":"285","author":"Kaneko","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.arbres.2009.10.008_bib45","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(05)63510-6","article-title":"Induction by antitumoral drugs of proteins that functionally complement CFTR: A novel therapy for cystic fibrosis?","volume":"350","author":"Lallemand","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2009.10.008_bib46","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0140-6736(05)79350-8","article-title":"Azitromycin, the multidrug-resistant protein and cystic fibrosis","volume":"351","author":"Altschuler","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2009.10.008_bib47","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1179\/joc.2005.17.4.393","article-title":"Long-term azithromycin in cystic fibrosis: Another possible mechanism of action?","volume":"17","author":"Pradal","year":"2005","journal-title":"J Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib48","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1179\/joc.2007.19.6.643","article-title":"Effects of azithromycin on the expression of ATP binding cassette transporters in epithelial cells from the airways of cystic fibrosis patients","volume":"19","author":"Cigana","year":"2007","journal-title":"J Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib49","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/AAC.50.5.1805-1812.2006","article-title":"Novel effects of azithromycin on tight junction proteins in human airway epithelia","volume":"50","author":"Asgrimsson","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10238-005-0070-7","article-title":"Autoantibodies against bactericidal\/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin","volume":"5","author":"Rotschild","year":"2005","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s101560050042","article-title":"Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: Suppression of virulence factors and stress response","volume":"6","author":"Tateda","year":"2000","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib52","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1128\/AAC.40.10.2271","article-title":"Direct evidence for antipseudomonal activity of macrolides: Exposure dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin","volume":"40","author":"Tateda","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib53","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1128\/JCM.42.12.5842-5845.2004","article-title":"Azithromycin retards Pseudomonas aeruginosa biofilm formation","volume":"42","author":"Gillis","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.arbres.2009.10.008_bib54","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1128\/AAC.49.9.3858-3867.2005","article-title":"Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms","volume":"49","author":"Gillis","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/jinf.2002.1120","article-title":"Quorum sensing and its relevance to infectious diseases","volume":"46","author":"Donabedian","year":"2003","journal-title":"J Infect"},{"key":"10.1016\/j.arbres.2009.10.008_bib56","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1093\/emboj\/cdg366","article-title":"Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors","volume":"22","author":"Hentzer","year":"2003","journal-title":"EMBOJ"},{"key":"10.1016\/j.arbres.2009.10.008_bib57","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.50.5.1680-1688.2006","article-title":"Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: A global approach","volume":"50","author":"Nalca","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib58","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1128\/AAC.45.6.1930-1933.2001","article-title":"Azithromycin inhibits quorum-sensing in Pseudomonas aeruginosa","volume":"45","author":"Tateda","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib59","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10156-007-0555-2","article-title":"Supression of Pseudomonas aeruginosa quorum-sensing systems by macrolides: A promising strategy or an oriental mystery?","volume":"13","author":"Tateda","year":"2007","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib60","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/jac\/dkf013","article-title":"Effect of clarithromyin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model","volume":"49","author":"Yanagihara","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s101560050049","article-title":"Influence of macrolides on guanosine diphospho-D-mannose dehydrogenase activity in Pseudomonas biofilm","volume":"6","author":"Mitsuya","year":"2000","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib62","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1128\/AAC.44.10.2869-2872.2000","article-title":"Effect of sub-inhibitory concentrations of macrolides on expresion of flagellin in Pseudomonas aeruginosa and Proteus mirabilis","volume":"44","author":"Kawamura-Sato","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0091-6749(74)90027-X","article-title":"Troleandomycin: Effectiveness in steroid dependent asthma and bronchitis","volume":"54","author":"Spector","year":"1974","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.arbres.2009.10.008_bib64","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib65","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/thx.49.6.531","article-title":"Diffuse panbronchiolitis and cystic fibrosis: East meets West","volume":"49","author":"Hoiby","year":"1994","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2009.10.008_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/dkh309","article-title":"Macrolide activities beyond their antimicrobial effects: Macrolides in diffuse panbronchiolitis and cystic fibrosis","volume":"54","author":"Schultz","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1164\/ajrccm\/147.1.153","article-title":"A mechanism of erythromycin treatment in patients with diffuse panbrochiolitis","volume":"147","author":"Kadota","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.arbres.2009.10.008_bib68","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0954-6111(03)00042-8","article-title":"Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis","volume":"97","author":"Kadota","year":"2003","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib69","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(05)78360-4","article-title":"Long-term azithromycin may improve lung function in children with cystic fibrosis","volume":"351","author":"Jaff\u00e9","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2009.10.008_bib70","article-title":"Effect of chronic azithromycin on lung fuction in cystic fibrosis","volume":"19","author":"Anstead","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arbres.2009.10.008_bib71","first-page":"244a","article-title":"Prolonged effect of chronic azithromycin therapy on lung funtiton in cystic fibrosis","volume":"20","author":"Anstead","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arbres.2009.10.008_bib72","first-page":"263","article-title":"Long term macrolide antibiotics improves pulmonary function in cystic fibrosis","volume":"19","author":"Pirzada","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arbres.2009.10.008_bib73","first-page":"244","article-title":"Effects of long-term azitromycin treatment of patient with CF and chronic P. aeruginosa infection","volume":"20","author":"Hansen","year":"2000","journal-title":"Pediatric Pulmonol"},{"key":"10.1016\/j.arbres.2009.10.008_bib74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1569-1993(03)00021-3","article-title":"Improved lung function and body mass index associated with long-term use of macrolide antibiotics","volume":"2","author":"Pirzada","year":"2003","journal-title":"J Cystic Fibrosis"},{"key":"10.1016\/j.arbres.2009.10.008_bib75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jcf.2004.09.001","article-title":"Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study","volume":"4","author":"Hansen","year":"2005","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2009.10.008_bib76","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/thorax.57.3.212","article-title":"Effect of long-term treatment with azithromycin on disease parameters in cystic fibrosis: A randomized trial","volume":"57","author":"Wolter","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2009.10.008_bib77","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","article-title":"Long term azithromycin in children with cystic fibrosis: A randomised, placebo-controlled crossover trial","volume":"360","author":"Equi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2009.10.008_bib78","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with pseudomonas aeruginosa: A randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.arbres.2009.10.008_bib79","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ppul.20620","article-title":"Clinical response to azithromycin in cystic fibrosis correlates with in intro effects on Pseudomonas aeruginosa phenotypes","volume":"42","author":"Nguyen","year":"2007","journal-title":"Paediatr Pulmonol"},{"key":"10.1016\/j.arbres.2009.10.008_bib80","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/thx.2005.057950","article-title":"Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial","volume":"61","author":"Clement","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2009.10.008_bib81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1183\/09031936.00163306","article-title":"Daily versus weekly azithromycin in cystic fibrosis patients","volume":"30","author":"McCormack","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2009.10.008_bib82","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.rmed.2008.03.009","article-title":"Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection","volume":"102","author":"Steinkamp","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ppul.1085","article-title":"Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: A pilot study","volume":"32","author":"Ordo\u00f1ez","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.arbres.2009.10.008_bib84","doi-asserted-by":"crossref","unstructured":"Richeldi L, Ferrara G, Fabbri LM, Lasserson TJ, Gibson PG. Macr\u00f3lidos para el asma cr\u00f3nica (revisi\u00f3n Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 n\u00famero 4 (Macrolides for chronic asthma, Review. Cochrane Database Syst Rev. 2005;CD002997).","DOI":"10.1002\/14651858.CD002997.pub3"},{"key":"10.1016\/j.arbres.2009.10.008_bib85","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","article-title":"Clarithromycin targets neutrophilic airway inflammation in refractory asthma","volume":"177","author":"Simpson","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib86","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1081-1206(10)60935-0","article-title":"Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: A double-blind, randomized, placebo-controlled trial","volume":"97","author":"Fonseca-Aten","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.arbres.2009.10.008_bib87","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2500\/aap.2007.28.2958","article-title":"Azithromycin reduces bronchial hyper-responsiveness and neutrophilic airway inflammation in asthmatic children: A preliminary report","volume":"28","author":"Piacentini","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.arbres.2009.10.008_bib88","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1371\/journal.pctr.0010011","article-title":"Secundary outcomes of a pilot randomized trial of azithromycin treatment for asthma","volume":"1","author":"Hahn","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"10.1016\/j.arbres.2009.10.008_bib89","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2005.05.023","article-title":"Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short term azithromycin treatment","volume":"517","author":"Parnham","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.arbres.2009.10.008_bib90","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1345\/aph.1D634","article-title":"The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: Preliminary data","volume":"38","author":"Basyigit","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.arbres.2009.10.008_bib91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1164\/rccm.200711-1666OC","article-title":"Azithromycin improves macrophage phagocytic function and expression of mannose receptor in COPD","volume":"178","author":"Hodge","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib92","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1183\/09031936.06.00001506","article-title":"Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages","volume":"28","author":"Hodge","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2009.10.008_bib93","first-page":"338S","article-title":"The effects of oral clarithromycin on airway inflammation in moderate to severe chronic obstructive pulmonary disease (COPD): A double blind randomized controlled study","volume":"18","author":"Benarjee","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2009.10.008_bib94","first-page":"153S","article-title":"The effect of 3 months oral clarithromycin on sputum bacterial colonization in stable moderate to severe chronic obstructive pulmonary disease (COPD)","volume":"18","author":"Banerjee","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2009.10.008_bib95","first-page":"94S","article-title":"The relationship between pulmonary function, health status, shuttle walk distance with sputum airway inflammation in moderate to severe chronic obstructive pulmonary disease (COPD)","volume":"18","author":"Banarjee","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2009.10.008_bib96","first-page":"S115","article-title":"Effect of long-term erythromycin in COPD trial (ELECT): Exacerbations and inflamation","volume":"62","author":"Wilkison","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2009.10.008_bib97","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib98","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.99.13236199","article-title":"A pilot study of low-dose erythromycin in bronchiectasis","volume":"13","author":"Tsang","year":"1999","journal-title":"Eur Resp Journ"},{"key":"10.1016\/j.arbres.2009.10.008_bib99","first-page":"540","article-title":"Prophylactic antibiotic treatment of bronchiectasis with azithromycin","volume":"59","author":"Davies","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2009.10.008_bib100","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1183\/09031936.97.10050994","article-title":"Effect of roxithromycin on airway responsiveness in children with bronchiectasis: A double-blind, placebo-controlled study","volume":"10","author":"Koh","year":"1997","journal-title":"Eur Resp Journ"},{"key":"10.1016\/j.arbres.2009.10.008_bib101","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2710.2006.00708.x","article-title":"Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis","volume":"31","author":"Yal\u00e7in","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.arbres.2009.10.008_bib102","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200504020-00005","article-title":"The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis","volume":"4","author":"Cymbala","year":"2005","journal-title":"Treat Respir Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib103","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1579-2129(06)60226-7","article-title":"Long-term treatment with azithromycin in a patient with idiopathic bronchiectasis","volume":"41","author":"Maiz Carro","year":"2005","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2009.10.008_bib104","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1579-2129(06)60446-1","article-title":"Bronchiectasis and macrolides","volume":"42","author":"Vila-Justribo","year":"2006","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2009.10.008_bib105","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.rmed.2008.06.005","article-title":"Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis","volume":"102","author":"Anwar","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib106","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2739\/kurumemedj.40.65","article-title":"Low-dose\/long-term erythromycin for treatment of bronchiolitis obliterans organizing pneumonia (BOOP) [Abstract]","volume":"40","author":"Ichikawa","year":"1993","journal-title":"Kurume Med J"},{"key":"10.1016\/j.arbres.2009.10.008_bib107","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/sj.bmt.1702642","article-title":"Improvement in bronchiolitis obliterans organizing pneumonia in a child after allogeneic bone marrow transplantation by a combination of oral prednisolone and low dose erythromycin","volume":"26","author":"Ishii","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.arbres.2009.10.008_bib108","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1164\/rccm.200212-1424BC","article-title":"Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: Results of a pilot study","volume":"168","author":"Gerhardt","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib109","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/01.TP.0000122412.80864.43","article-title":"Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation","volume":"77","author":"Verleden","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.arbres.2009.10.008_bib110","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1183\/09031936.05.00020804","article-title":"Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: A preliminary study","volume":"25","author":"Khalid","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2009.10.008_bib111","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1164\/rccm.200411-1537OC","article-title":"Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome","volume":"172","author":"Yates","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib112","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/rccm.200601-071OC","article-title":"Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome","volume":"174","author":"Verleden","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib113","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000295981.84633.bc","article-title":"Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation","volume":"85","author":"Gottlieb","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.arbres.2009.10.008_bib114","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.healun.2004.08.006","article-title":"Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients","volume":"24","author":"Shitrit","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.arbres.2009.10.008_bib115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1164\/ajrccm.173.4.465","article-title":"Azithromycin in bronchiolitis obliterans: Is the evidence strong enough?","volume":"173","author":"Angel","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib116","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1164\/ajrccm.169.5.952","article-title":"Azithromycin and bronchiolitis obliterans","volume":"169","author":"Kanazawa","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2009.10.008_bib117","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2006.01586.x","article-title":"Macrolides inhibit IL-17-induced IL-8 and 8-isoprostane release from human airway smooth muscle cells","volume":"7","author":"Vanaudenaerde","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.arbres.2009.10.008_bib118","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1378\/chest.128.5.3611","article-title":"Macrolides: A treatment alternative for bronchiolitis obliterans organizing pneumonia?","volume":"128","author":"Stover","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2009.10.008_bib119","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/dkl014","article-title":"Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis","volume":"57","author":"Phaff","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.inf.0000247109.44249.ac","article-title":"Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: Long-term outcomes related to macrolide resistance and pulmonary function","volume":"26","author":"Tramper-Straders","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.arbres.2009.10.008_bib121","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10156-005-0375-1","article-title":"Macrolide resistance of Streptococcus pneumoniae isolated during long-term macrolide therapy: Difference between erythromycin and clarithromycin","volume":"11","author":"Kasahara","year":"2005","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.arbres.2009.10.008_bib122","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jcf.2008.09.001","article-title":"Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients","volume":"8","author":"Hansen","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2009.10.008_bib123","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1579-2129(08)60036-1","article-title":"Macrolides: Not just antibiotics","volume":"44","author":"Gir\u00f3n","year":"2008","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2009.10.008_bib124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1465-9921-8-41","article-title":"Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: A pilot study","volume":"8","author":"Ballard","year":"2007","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2009.10.008_bib125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.07-2786","article-title":"Beneficial response to macrolide antibiotic in patient with desquamative interstitial Pneumonia refractory to corticosteroid therapy","volume":"134","author":"Knyazhitskiy","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2009.10.008_bib126","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1067\/mhn.2002.124849","article-title":"One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: Clinical outcome and effects on mucociliary parameters and nasal nitric oxide","volume":"126","author":"Cervin","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.arbres.2009.10.008_bib127","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01.mlg.0000191560.53555.08","article-title":"A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis","volume":"116","author":"Wallwork","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.arbres.2009.10.008_bib128","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00005537-200402000-00019","article-title":"Effect of clarithromycin on nuclear factor \u03baB and transforming growth factor-\u00df in chronic rhinosinusitis","volume":"114","author":"Wallwork","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.arbres.2009.10.008_bib129","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2146\/ajhp060539","article-title":"Azithromycin for the secondary prevention of coronary artery disease: A meta-analysis","volume":"64","author":"Baker","year":"2007","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.arbres.2009.10.008_bib130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2230.2006.02322.x","article-title":"The effect of azithromycin on reactive oxygen species in rosacea","volume":"32","author":"Bakar","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.arbres.2009.10.008_bib131","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-4632.2004.01958.x","article-title":"Therapeutic potential of azithromycin in rosacea","volume":"43","author":"Bakar","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.arbres.2009.10.008_bib132","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2230.2007.02370.x","article-title":"Efficacy of erythromycin for psoriasis vulgaris","volume":"32","author":"Polat","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.arbres.2009.10.008_bib133","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1346-8138.2000.tb02217.x","article-title":"An open trial of oral macrolide treatment for psoriasis vulgaris","volume":"27","author":"Komine","year":"2000","journal-title":"J Dermatol"},{"key":"10.1016\/j.arbres.2009.10.008_bib134","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1440-1746.2006.04533.x","article-title":"Open label trial of clarithromycin therapy in Japanese patients with Crohn's disease","volume":"22","author":"Inoue","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.arbres.2009.10.008_bib135","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1365-2036.2008.03661.x","article-title":"Clinical trial: Randomized study of clarithromycin versus placebo in active Crohn's disease","volume":"27","author":"Leiper","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arbres.2009.10.008_bib136","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1365-2036.2000.00753.x","article-title":"Open label trial of oral clarithromycin in active Crohn's disease","volume":"14","author":"Leiper","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arbres.2009.10.008_bib137","first-page":"352","article-title":"Azithromycin: An anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report","volume":"59","author":"Shcilling","year":"2000","journal-title":"Z Reumatol"},{"key":"10.1016\/j.arbres.2009.10.008_bib138","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/ard.2003.010710","article-title":"Three month treatment of reactive arthritis with azithromycin: A EULAR double blind, placebo controlled study","volume":"63","author":"Kvien","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arbres.2009.10.008_bib139","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-9657.2005.00294.x","article-title":"Evaluation of the anti-inflammatory effect of erythromycin on aseptic inflammation of temporo-mandibular joint in rabbit: A scintigraphic and histopathologic study","volume":"21","author":"Ertas","year":"2005","journal-title":"Dent Traumatol"},{"key":"10.1016\/j.arbres.2009.10.008_bib140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.semarthrit.2006.04.005","article-title":"Open-label study of claritrhomycin in patients with undifferentiated connective tissue disease","volume":"36","author":"Moskowitz","year":"2006","journal-title":"Semin Arthritis Rheum"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289609004268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289609004268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T17:02:15Z","timestamp":1739466135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289609004268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":140,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0300289609004268"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2009.10.008","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}